COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH:

Key Record Dates Identifier: NCT03674177
Brief Title: A Study to Evaluate Different Dose Levels of GlaxoSmithKline (GSK) Biologicals' Investigational Respiratory Syncytial Virus (RSV) Vaccine (GSK3888550A), Based on the Vaccine Safety and the Antibodies (Body Defences) Produced Following Vaccine Administration, When Given to Healthy Non-pregnant Women

First Submitted : September 14, 2018
First Submitted that Met QC Criteria : September 14, 2018
First Posted : September 17, 2018

Last Update Submitted that Met QC Criteria : October 3, 2019
Last Update Posted : October 4, 2019